SURGIVAL (GRUPO COSÍAS) consists of three companies specialized in the production, marketing and distribution of implants for traumatology, prosthesis for orthopedic surgery and surgical instrumentation. Its venture into the orthopaedic field began during the 80´s with a company known as ORBIMED whose main activity was distributing imported products of the best companies in the world at that time, a job that we still carry out today. ORBIMED was the origin of our business projection and helped us to learn that the combination of product quality and service excellence would enable us to reach our goals and therefore the satisfaction of our customers. The trusting link that we have created with our customers has strengthened our position in the national market. In 1985, SURGIVAL began in Valencia. I

nitially, it was created to specialize in osteosynthesis production. In 1995, ORBIMED decided to purchase 100% of SURGIVAL, owned by the G. Cremascoli multinational company. That was when our new stage began, leading to the following activities: Production Plant Modernization incorporating the latest innovations in production with numeric control machines.Redesign of the Quality Control Department introducing the highest technology to guarantee maximum quality in our products.Creation of the R+D+i Department enabling the development of many strategical projects in the main lines of products. “SURGIVAL has become the national leader of sales and is firmly secured in the international market, and is supported by the best medical teams and prestigious companies that represent us in the five continents”.

“SURGIVAL is a synonym of excellence in quality and service”. Our effort, hard work, persistence and success were rewarded with the opening of SURGIVAL TRAUMA in 2005. This new production plant was created with the strategic aim of diversifying and specializing in our plant production. Its design meant that its production could focus on osteosynthesis and the instrumentation, covering the current high demand. SURGIVAL focuses exclusively on manufacturing high added value orthopaedic products using state-of-the-art technology. In 2007, ORBIMED became SURGIVAL COMERCIAL.